{"id":"jincaopian-tablets-low-dose","_chembl":{"chemblId":"CHEMBL2108580","moleculeType":"Unknown"},"modality":"Small molecule","_dailymed":null,"_scrapedAt":"2026-03-28T01:57:27.537Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_claudeStub":{"ts":1779122982,"model":"claude-sonnet-4-5-20250929"},"description":"Jincaopian Tablets low dose is an investigational traditional Chinese medicine formulation developed by Beijing Konruns Pharmaceutical Co., Ltd. currently in Phase 2 clinical development. The specific molecular target, mechanism of action, and therapeutic indication have not been publicly disclosed.","indications":{"approved":[{"status":"investigational","condition":null,"patientPopulation":null}]},"trialDetails":[{"nctId":"NCT05460546","phase":"PHASE2","title":"The Effect of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease","status":"COMPLETED","sponsor":"Beijing Konruns Pharmaceutical Co., Ltd.","startDate":"2021-01-19","conditions":"Chronic Pelvic Pain","enrollment":180}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1187,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["ZY5301"],"phase":"phase_2","status":"active","brandName":"Jincaopian Tablets low dose","genericName":"Jincaopian Tablets low dose","companyName":"Beijing Konruns Pharmaceutical Co., Ltd.","companyId":"beijing-konruns-pharmaceutical-co-ltd","firstApprovalDate":"","aiSummary":"","enrichmentLevel":1,"visitCount":2,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}